Device Medical Device

(Bj6) Epiq Elite G

Payments companies reported to CMS as associated with (Bj6) Epiq Elite G. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$2,925associated payments (2023-2025)

27clinicians with associated payments

1company reporting

By year

2024 $2,925

Payments reported as associated with (Bj6) Epiq Elite G, per program year, as reported to CMS.

Who makes it

Philips North America LLC $2,925 associated with (Bj6) Epiq Elite G (2023-2025)

Specialties most often involved

Vascular & Interventional Radiology $2,073

Diagnostic Radiology $810

Pediatric Radiology $28.30

Body Imaging $14.15

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with (Bj6) Epiq Elite G

These are the largest totals companies reported as associated with (Bj6) Epiq Elite G. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

Clinician	Location	Specialty	Associated payments (2023-2025)
Brian Schiro	Miami, FL	Vascular & Interventional Radiology	$1,301.67
Richard Barr	Youngstown, OH	Diagnostic Radiology	$151.86
Paul Karlinsky	Tavares, FL	Diagnostic Radiology	$113.34
Gabriel Werder	Melbourne, FL	Diagnostic Radiology	$113.33
John Melnick	New York, NY	Diagnostic Radiology	$110.02
Jason Sinner	Burbank, CA	Diagnostic Radiology	$110.02
Ray Jensen	Seattle, WA	Vascular & Interventional Radiology	$97.67
Rochelle Andreotti	Nashville, TN	Diagnostic Radiology	$91.76
Ashutosh Rao	Marietta, GA	Vascular & Interventional Radiology	$86.00
Nathan Ertel	Marietta, GA	Vascular & Interventional Radiology	$86.00

Prescribed (Bj6) Epiq Elite G?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

What this means, and what it doesn't

These payments are legal and common. Drug and device makers routinely pay for meals at educational events, consulting, speaking, travel, and research. Companies are required by federal law to report them; that's why this data exists.
A payment is not evidence of wrongdoing. Most clinicians who accept industry payments provide excellent care. Research payments in particular often reflect participation in clinical trials.
Context beats raw numbers. A few hundred dollars in sandwiches over several years is typical. What's worth understanding is scale, source, and purpose, which is what this page shows.
The data comes from companies, not doctors. Figures are "as reported to CMS" by the paying companies. Clinicians can dispute records through CMS's official process.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.